Leonard A Smith - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Leonard A Smith

Showing results (41-50 of 86) with videos related to

Pageof 9

Sort By:

Frontiers in Pharmacology|June 8, 2012

Tyrosine phosphorylation of botulinum neurotoxin protease domainsStephen Toth, Ernst E Brueggmann, George A Oyler, et al.

The Journal of Biological Chemistry|June 20, 2013

The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active siteRahman M Mizanur, Verna Frasca, Subramanyam Swaminathan, et al.

Protein Engineering, Design & Selection : PEDS|June 10, 2004

Finding a new vaccine in the ricin protein foldMark A Olson, John H Carra, Virginia Roxas-Duncan, et al.

The Journal of Biological Chemistry|September 11, 2002

Clostridium perfringens iota toxin. Mapping of the Ia domain involved in docking with Ib and cellular internalizationJean-Christophe Marvaud, Bradley G Stiles, Alexandre Chenal, et al.

Journal of Industrial Microbiology & Biotechnology|April 11, 2003

Pichia pastoris fermentation with mixed-feeds of glycerol and methanol: growth kinetics and production improvementWenhui Zhang, Karen J Hywood Potter, Bradley A Plantz, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|October 12, 2011

Protective effect of two recombinant ricin subunit vaccines in the New Zealand white rabbit subjected to a lethal aerosolized ricin challenge: survival, immunological response, and histopathological findingsDaniel E McLain, Bridget S Lewis, Jennifer L Chapman, et al.

Vaccine|March 31, 2007

Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxinsRobert P Webb, Theresa J Smith, Patrick M Wright, et al.

Human Vaccines & Immunotherapeutics|January 27, 2016

Recent advances in the development of vaccines against ricinRobert N Brey, Nicholas J Mantis, Seth H Pincus, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004

Roads from vaccines to therapiesLeonard A Smith, Melody J Jensen, Vicki A Montgomery, et al.

Applied and Environmental Microbiology|December 21, 2010

Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxinsSuzanne R Kalb, Jakub Baudys, Christina Egan, et al.

Pageof 9

Search research articles

Showing results (41-50 of 86) with videos related to

Sort By:

Pageof 9

Frontiers in Pharmacology|June 8, 2012

Tyrosine phosphorylation of botulinum neurotoxin protease domainsStephen Toth, Ernst E Brueggmann, George A Oyler, et al.

The Journal of Biological Chemistry|June 20, 2013

The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active siteRahman M Mizanur, Verna Frasca, Subramanyam Swaminathan, et al.

Protein Engineering, Design & Selection : PEDS|June 10, 2004

Finding a new vaccine in the ricin protein foldMark A Olson, John H Carra, Virginia Roxas-Duncan, et al.

The Journal of Biological Chemistry|September 11, 2002

Clostridium perfringens iota toxin. Mapping of the Ia domain involved in docking with Ib and cellular internalizationJean-Christophe Marvaud, Bradley G Stiles, Alexandre Chenal, et al.

Journal of Industrial Microbiology & Biotechnology|April 11, 2003

Pichia pastoris fermentation with mixed-feeds of glycerol and methanol: growth kinetics and production improvementWenhui Zhang, Karen J Hywood Potter, Bradley A Plantz, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|October 12, 2011

Vaccine|March 31, 2007

Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxinsRobert P Webb, Theresa J Smith, Patrick M Wright, et al.

Human Vaccines & Immunotherapeutics|January 27, 2016

Recent advances in the development of vaccines against ricinRobert N Brey, Nicholas J Mantis, Seth H Pincus, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004

Roads from vaccines to therapiesLeonard A Smith, Melody J Jensen, Vicki A Montgomery, et al.

Applied and Environmental Microbiology|December 21, 2010

Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxinsSuzanne R Kalb, Jakub Baudys, Christina Egan, et al.

Pageof 9